Clinical Trials
2
Active:0
Completed:2
Trial Phases
2 Phases
Phase 1:1
Phase 2:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (50.0%)Phase 2
1 (50.0%)Safety, Tolerability and Pharmacokinetic Study of LTI-03 in Healthy Adult Subjects
Phase 1
Completed
- Conditions
- Idiopathic Pulmonary Fibrosis
- Interventions
- First Posted Date
- 2020-01-18
- Last Posted Date
- 2022-03-07
- Lead Sponsor
- Lung Therapeutics, Inc
- Target Recruit Count
- 71
- Registration Number
- NCT04233814
- Locations
- 🇬🇧
Celerion, Belfast, United Kingdom
A Study to Evaluate LTI-01 in Patients With Infected, Non-draining Pleural Effusions
- First Posted Date
- 2019-11-12
- Last Posted Date
- 2023-03-30
- Lead Sponsor
- Lung Therapeutics, Inc
- Target Recruit Count
- 44
- Registration Number
- NCT04159831
- Locations
- 🇺🇸
The University of Alabama at Birmingham, Birmingham, Alabama, United States
🇺🇸UC San Diego Health Jacobs Medical Center, La Jolla, California, United States
🇺🇸University of California (UCLA), Los Angeles, California, United States
News
No news found